20 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.

Instituto De Qu£Mica M£Dica
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.

University of North Carolina At Greensboro
Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors.

University of Bonn
8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.

University of Bonn
Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.

University of Bonn
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.

University of Bonn
Emerging targets in osteoporosis disease modification.

Amgen
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.

IQM-CSIC
Phytocannabinoid Pharmacology: Medicinal Properties of

Scientus Pharma
Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.

University of Bonn
The Essential Medicinal Chemistry of Cannabidiol (CBD).

University of Minnesota
Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55.

University of Calabria
Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.

University of Eastern Finland
Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.

University of Bonn
Design, synthesis and biological evaluation of GPR55 agonists.

University of North Carolina At Greensboro
Diaryl macrocycles as modulators of protein kinases

Tp Therapeutics
Biaryl kinase inhibitors

Bristol-Myers Squibb
Compounds useful for treating disorders related to RET

Blueprint Medicines
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-Benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.

Seoul National University
Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains.

Yale University